TSP Capital Management Group’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
S
OAM
SO
AA
PAG
PFSRSONJ
YIH
TSP Capital Management Group's NVAX Position: Q2 2026 in Review
TSP Capital Management Group opened a new position in Novavax (NVAX) in Q2 2026: 1,419,365 shares worth $13.4M. The stake represents 3.2% of the portfolio and ranks #14 among its holdings. This is a return to the name: TSP Capital Management Group previously reported a position in NVAX as recently as Q3 2025.
TSP Capital Management Group first reported a position in NVAX in Q4 2020 and has held it in 14 quarters since. The position peaked at $17.4M in Q2 2024. 64 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- TSP Capital Management Group held 1,419,365 shares of Novavax worth $13.4M as of Q2 2026.
- Novavax was a new TSP Capital Management Group position in Q2 2026.
- Novavax made up 3.2% of TSP Capital Management Group's portfolio in Q2 2026, its #14 holding.
- TSP Capital Management Group first reported a position in Novavax in Q4 2020 and has held it in 14 quarters since.
- TSP Capital Management Group's Novavax position peaked at $17.4M in Q2 2024.
- 64 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on TSP Capital Management Group's 13F filing for Q2 2026, filed 31 Jul 2026.